Skip to main content
. 2015 Aug 30;15(8):e29282. doi: 10.5812/hepatmon.29282

Figure 4. Effect of Antibody Against Type I IFN Receptor (IFNAR2) on Macrophages Supernatant (SN)-Mediated anti-HCV Activity.

Figure 4.

HCV JFH-1-infected Huh7 cells (day 3 postinfection) were pretreated with antibody to IFNAR2 or control IgG at the concentration of 5 μg/mL for one hour followed with SN (10%, v/v) from NS-3’NTR dsRNA-stimulated macrophages culture for 48 hours. HCV JFH-1 replication was measured by real-time RT-PCR for HCV RNA. Data was expressed as HCV RNA levels relative (%) to control (* P < 0.05).